MiRNA-494 inhibits metastasis of cervical cancer through Pttg1. (Q41067887)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

26 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

MiRNA-494 inhibits metastasis of cervical cancer through Pttg1. (English)

1 reference

26 September 2017

main subject

cervix uterine cancer

1 reference

Bing Chen

1

1 reference

26 September 2017

Zhaohui Hou

series ordinal

2

1 reference

26 September 2017

Chundong Li

series ordinal

3

1 reference

26 September 2017

Ying Tong

series ordinal

4

1 reference

26 September 2017

publication date

16 April 2015

1 reference

26 September 2017

1 reference

26 September 2017

volume

36

1 reference

26 September 2017

issue

9

1 reference

26 September 2017

page(s)

7143-7149

1 reference

Rapid growth of cervical cancer metastasis in the brain

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

Molecular regulation of cervical cancer growth and invasion by VEGFa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

Pituitary tumor transforming gene (PTTG) regulates placental JEG-3 cell division and survival: evidence from live cell imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

Down-regulation of the PTTG1 proto-oncogene contributes to the melanoma suppressive effects of the cyclin-dependent kinase inhibitor PHA-848125

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

Pituitary tumor-transforming gene: physiology and implications for tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

The emerging role of pituitary tumor transforming gene in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

PTTG: an important target gene for ovarian cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

Inhibitory effects of anti-sense PTTG on malignant phenotype of human ovarian carcinoma cell line SK-OV-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

PTTG overexpression promotes lymph node metastasis in human esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

Overexpression of human pituitary tumor transforming gene (hPTTG), is regulated by beta-catenin /TCF pathway in human esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

Identification of over-expressed genes in human renal cell carcinoma by combining suppression subtractive hybridization and cDNA library array

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

PTTG acts as a STAT3 target gene for colorectal cancer cell growth and motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

Securin induces genetic instability in colorectal cancer by inhibiting double-stranded DNA repair activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

RNAi-mediated knockdown of pituitary tumor- transforming gene-1 (PTTG1) suppresses the proliferation and invasive potential of PC3 human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

PTTG1 inhibits SMAD3 in prostate cancer cells to promote their proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

Prostate cancer cell response to paclitaxel is affected by abnormally expressed securin PTTG1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

Garlic constituent diallyl trisulfide prevents development of poorly differentiated prostate cancer and pulmonary metastasis multiplicity in TRAMP mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

A mouse stromal response to tumor invasion predicts prostate and breast cancer patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

E2F4 regulates a stable G2 arrest response to genotoxic stress in prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

miRNA profiling of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

Delivering the promise of miRNA cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

miR-494 acts as an anti-oncogene in gastric carcinoma by targeting c-myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

Overexpression of secretagogin inhibits cell apoptosis and induces chemoresistance in small cell lung cancer under the regulation of miR-494

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

miR-494 represses HOXA10 expression and inhibits cell proliferation in oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

Irradiation-induced angiogenesis is associated with an MMP-9-miR-494-syndecan-1 regulatory loop in medulloblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

Clonal growth of mammalian cells in vitro; growth characteristics of colonies from single HeLa cells with and without a feeder layer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

Coordinated effects of microRNA-494 induce G₂/M arrest in human cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3440-0

Expression of PTTG (pituitary tumor transforming gene) in esophageal cancer

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/25877755

12 December 2020

Calcaneal metastasis in uterine cervical cancer: a case report and a review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/25877755

12 December 2020

Expression of pituitary tumor transforming gene 1 is an independent factor of poor prognosis in localized or locally advanced prostate cancer cases receiving hormone therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25877755

12 December 2020

Downregulation of protein tyrosine phosphatase PTPL1 alters cell cycle and upregulates invasion-related genes in prostate cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/25877755

12 December 2020

Small interfering RNA against PTTG: a novel therapy for ovarian cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25877755

12 December 2020

Ionizing radiation-inducible miR-494 promotes glioma cell invasion through EGFR stabilization by targeting p190B rhoGAP.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25877755

12 December 2020

Cinobufacin suppresses cell proliferation via miR-494 in BGC- 823 gastric cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/25877755

12 December 2020

miR-186, miR-3651 and miR-494: Potential biomarkers for oral squamous cell carcinoma extracted from whole blood

1 reference

https://pubmed.ncbi.nlm.nih.gov/25877755

12 December 2020

Significance of pituitary tumor transforming gene 1 (PTTG1) in prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25877755

12 December 2020

Pituitary tumor-transforming gene (PTTG): a novel target for anti-tumor therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25877755

12 December 2020

Epigenetic changes of pituitary tumor-derived transforming gene 1 in pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25877755

12 December 2020

Cerebral metastasis of cervical cancer, report of two cases and review of the literature.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25877755

12 December 2020

10.1007/S13277-015-3440-0

Identifiers

DOI

1 reference

Dimensions Publication ID

26 September 2017

1019732538

0 references

1 reference